DongBang Medical Co., Ltd. Q3 profit from the main business KRW 5.4 billion, up 33.7% from a year earlier
AI summary · Not investment advice
In Q3, the company sold KRW 29.3 billion worth and earned KRW 5.4 billion from its main business, up 33.7% from a year earlier and down 14.5% from the prior quarter.
Operating profit · 3 months
KRW 5.4 billion
Key facts
- Revenue (3 months)
- KRW 29.3 billion
- Net income (3 months)
- KRW 2.5 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 30.0 billion
- Revenue (year to date)
- KRW 94.6 billion
- Operating profit (prior-year 3 months)
- KRW 4.1 billion
- Operating profit (year to date)
- KRW 17.8 billion
- Net income (prior-year 3 months)
- KRW 2.8 billion
- Net income (year to date)
- KRW 11.8 billion
Commentary
AI commentary · Not investment advice
What happened
Dongbang Medical filed its quarterly report for the third quarter on a consolidated basis. Sales for the latest 3 months were KRW 29.27 billion. That is 2.4% lower than a year earlier and 13.8% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 5.43 billion. That is 33.7% higher than a year earlier and 14.5% lower than the previous quarter.
What changes for shareholders
Net income (final profit after taxes and other costs) for the 3 months was KRW 2.48 billion. That is 12.8% lower than a year earlier and 37.8% lower than the previous quarter.
For the year to date, from January 1 to September 30, sales were KRW 94.61 billion. Operating profit was KRW 17.84 billion. Net income was KRW 11.75 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D